{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T04:49:43Z","timestamp":1777092583818,"version":"3.51.4"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,24]],"date-time":"2025-05-24T00:00:00Z","timestamp":1748044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,24]],"date-time":"2025-05-24T00:00:00Z","timestamp":1748044800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"NTNU Norwegian University of Science and Technology"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Women's Health"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Women with substance use disorder (SUD) face a higher risk of sexual assault, abuse, cervical premalignant lesions, and unplanned pregnancy compared to the general female population. To meet the specific needs of this vulnerable group, we established a comprehensive gynecological service. The study aimed to describe the characteristics of women with SUD who accessed these services. Furthermore, we evaluated their cervical cytology and sexually transmitted infections (STIs) test results, preferred contraceptive methods, and the overall acceptability of the service.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>We enrolled 48 women undergoing outpatient or inpatient treatment for SUD in the South-Tr\u00f8ndelag region of Norway in the study. Each women received a comprehensive gynecological anamnesis, including a history of sexual assault, followed by a gynecological examination at the outpatient clinic of the Department of Obstetrics and Gynecology. The examination included ThinPrep Tests and microbiological swabs. They were also offered contraception options, with an emphasis on Long Acting Reversible Contraceptives (LARC), at no cost. Participants provided feedback on the service immediately after their consultation and again six months later.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Nearly two-thirds (63%) of the women with a mean age 31.8, reported a history of sexual assault. One in three (33%) had cervical cytology or human pappilomavirus (HPV) test results necessitating treatment or follow-up, though no cases of sexually transmitted infections were found. Two thirds (66%) of eligible women chose LARC as their contraceptive method. Among the 23 women reached for a follow-up phone call six months later, all expressed high level of satisfaction with the service and indicated they would recommend it to other women in similar situations.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>An integrated, specialized gynecological service that provides cervical testing and contraceptive counselling can effectively reach women receiving outpatient or inpatient treatment for SUD, who typically fail to follow-up routine women\u2019s health screening programmes. If implemented, this approach has the potential to reduce unplanned pregnancies and improve early detection of cervical pathology in this vulnerable population.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s12905-025-03794-0","type":"journal-article","created":{"date-parts":[[2025,5,24]],"date-time":"2025-05-24T06:58:00Z","timestamp":1748069880000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Facilitating gynecological examination and long acting reversible contraception for women with substance use disorder: a prospective cohort study"],"prefix":"10.1186","volume":"25","author":[{"given":"Trine","family":"Finanger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ragnhild Bergene","family":"Skr\u00e5stad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"Appleton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cecilie Therese","family":"Hagemann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,24]]},"reference":[{"key":"3794_CR1","doi-asserted-by":"crossref","unstructured":"The global burden of disease attributable to alcohol and drug use in 195 countries and territories, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Psychiatry. 2018;5(12):987-1012.","DOI":"10.1016\/S2215-0366(18)30337-7"},{"key":"3794_CR2","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.cpr.2017.10.012","volume":"66","author":"RK McHugh","year":"2018","unstructured":"McHugh RK, Votaw VR, Sugarman DE, Greenfield SF. Sex and gender differences in substance use disorders. Clin Psychol Rev. 2018;66:12\u201323.","journal-title":"Clin Psychol Rev"},{"issue":"2","key":"3794_CR3","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.ogc.2014.02.001","volume":"41","author":"RK McHugh","year":"2014","unstructured":"McHugh RK, Wigderson S, Greenfield SF. Epidemiology of substance use in reproductive-age women. Obstet Gynecol Clin North Am. 2014;41(2):177\u201389.","journal-title":"Obstet Gynecol Clin North Am"},{"key":"3794_CR4","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.drugalcdep.2017.08.027","volume":"180","author":"SA Vasilenko","year":"2017","unstructured":"Vasilenko SA, Evans-Polce RJ, Lanza ST. Age trends in rates of substance use disorders across ages 18\u201390: Differences by gender and race\/ethnicity. Drug Alcohol Depend. 2017;180:260\u20134.","journal-title":"Drug Alcohol Depend"},{"issue":"2","key":"3794_CR5","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1080\/03009734.2019.1707913","volume":"125","author":"I Delbaere","year":"2020","unstructured":"Delbaere I, Verbiest S, Tyd\u00e9n T. Knowledge about the impact of age on fertility: a brief review. Ups J Med Sci. 2020;125(2):167\u201374.","journal-title":"Ups J Med Sci"},{"issue":"5","key":"3794_CR6","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1177\/1524838015584371","volume":"17","author":"JA Heerde","year":"2016","unstructured":"Heerde JA, Hemphill SA. Sexual Risk Behaviors, Sexual Offenses, and Sexual Victimization Among Homeless Youth: A Systematic Review of Associations With Substance Use. Trauma Violence Abuse. 2016;17(5):468\u201389.","journal-title":"Trauma Violence Abuse"},{"issue":"6","key":"3794_CR7","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/j.jflm.2013.05.005","volume":"20","author":"CT Hagemann","year":"2013","unstructured":"Hagemann CT, Helland A, Spigset O, Espnes KA, Ormstad K, Schei B. Ethanol and drug findings in women consulting a Sexual Assault Center\u2013associations with clinical characteristics and suspicions of drug-facilitated sexual assault. J Forensic Leg Med. 2013;20(6):777\u201384.","journal-title":"J Forensic Leg Med"},{"issue":"2","key":"3794_CR8","first-page":"111","volume":"9","author":"KA Chivers-Wilson","year":"2006","unstructured":"Chivers-Wilson KA. Sexual assault and posttraumatic stress disorder: a review of the biological, psychological and sociological factors and treatments. Mcgill J Med. 2006;9(2):111\u20138.","journal-title":"Mcgill J Med"},{"issue":"12","key":"3794_CR9","doi-asserted-by":"publisher","first-page":"2858","DOI":"10.1111\/jan.12745","volume":"71","author":"J Soccio","year":"2015","unstructured":"Soccio J, Brown M, Comino E, Friesen E. Pap smear screening, pap smear abnormalities and psychosocial risk factors among women in a residential alcohol and drug rehabilitation facility. J Adv Nurs. 2015;71(12):2858\u201366.","journal-title":"J Adv Nurs"},{"issue":"3","key":"3794_CR10","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1016\/j.ygyno.2020.12.011","volume":"160","author":"D Dahlman","year":"2021","unstructured":"Dahlman D, Li X, Magnusson H, Sundquist J, Sundquist K. Cervical cancer among Swedish women with drug use disorders: A nationwide epidemiological study. Gynecol Oncol. 2021;160(3):742\u20137.","journal-title":"Gynecol Oncol"},{"key":"3794_CR11","unstructured":"World Health Organization. Cervical cancer Geneva: World Health Organization; 2022 [Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/cervical-cancer."},{"issue":"12","key":"3794_CR12","doi-asserted-by":"publisher","first-page":"2861","DOI":"10.1111\/jan.12442","volume":"70","author":"NL Edelman","year":"2014","unstructured":"Edelman NL, Patel H, Glasper A, Bogen-Johnston L. Sexual health risks and health-seeking behaviours among substance-misusing women. J Adv Nurs. 2014;70(12):2861\u201370.","journal-title":"J Adv Nurs"},{"issue":"8","key":"3794_CR13","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1176\/appi.ps.201100301","volume":"63","author":"MT Abrams","year":"2012","unstructured":"Abrams MT, Myers CS, Feldman SM, Boddie-Willis C, Park J, McMahon RP, et al. Cervical cancer screening and acute care visits among Medicaid enrollees with mental and substance use disorders. Psychiatric services (Washington, DC). 2012;63(8):815\u201322.","journal-title":"Psychiatric services (Washington, DC)"},{"issue":"3","key":"3794_CR14","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/BF01314641","volume":"256","author":"B Sikstr\u00f6m","year":"1995","unstructured":"Sikstr\u00f6m B, Hellberg D, Nilsson S, M\u00e5rdh PA. Smoking, alcohol, sexual behaviour and drug use in women with cervical human papillomavirus infection. Arch Gynecol Obstet. 1995;256(3):131\u20137.","journal-title":"Arch Gynecol Obstet"},{"issue":"7","key":"3794_CR15","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1097\/OLQ.0000000000001341","volume":"48","author":"SA Strathdee","year":"2021","unstructured":"Strathdee SA, Bristow CC, Gaines T, Shoptaw S. Collateral damage: a narrative review on epidemics of substance use disorders and their relationships to sexually transmitted infections in the united states. Sex Transm Dis. 2021;48(7):466\u201373.","journal-title":"Sex Transm Dis"},{"issue":"13","key":"3794_CR16","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1177\/0956462420950603","volume":"31","author":"MR Haider","year":"2020","unstructured":"Haider MR, Kingori C, Brown MJ, Battle-Fisher M, Chertok IA. Illicit drug use and sexually transmitted infections among young adults in the US: evidence from a nationally representative survey. Int J STD AIDS. 2020;31(13):1238\u201346.","journal-title":"Int J STD AIDS"},{"key":"3794_CR17","doi-asserted-by":"publisher","first-page":"100248","DOI":"10.1016\/j.dadr.2024.100248","volume":"12","author":"JK Bello","year":"2024","unstructured":"Bello JK, Xu KY, Salas J, Kelly J, Grucza RA. Contraceptive uptake in postpartum people with and without opioid use disorder and opioid use with co-occurring substance use. Drug Alcohol Depend Rep. 2024;12:100248.","journal-title":"Drug Alcohol Depend Rep"},{"issue":"1","key":"3794_CR18","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s12954-017-0181-y","volume":"14","author":"V Clergue-Duval","year":"2017","unstructured":"Clergue-Duval V, Robin S, Fortias M, Dupuy G, Badin-de-Montjoye B, Vorspan F. Use and knowledge of contraceptive methods by patients in two substance use disorders treatment centers in Paris. Harm Reduct J. 2017;14(1):54.","journal-title":"Harm Reduct J"},{"key":"3794_CR19","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.ypmed.2015.04.008","volume":"80","author":"M Terplan","year":"2015","unstructured":"Terplan M, Hand DJ, Hutchinson M, Salisbury-Afshar E, Heil SH. Contraceptive use and method choice among women with opioid and other substance use disorders: A systematic review. Prev Med. 2015;80:23\u201331.","journal-title":"Prev Med"},{"issue":"3","key":"3794_CR20","doi-asserted-by":"publisher","first-page":"e0116231","DOI":"10.1371\/journal.pone.0116231","volume":"10","author":"CS Cornford","year":"2015","unstructured":"Cornford CS, Close HJ, Bray R, Beere D, Mason JM. Contraceptive use and pregnancy outcomes among opioid drug-using women: a retrospective cohort study. PLoS ONE. 2015;10(3):e0116231.","journal-title":"PLoS ONE"},{"issue":"2","key":"3794_CR21","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.ogc.2014.02.011","volume":"41","author":"HS Connery","year":"2014","unstructured":"Connery HS, Albright BB, Rodolico JM. Adolescent substance use and unplanned pregnancy: strategies for risk reduction. Obstet Gynecol Clin North Am. 2014;41(2):191\u2013203.","journal-title":"Obstet Gynecol Clin North Am"},{"issue":"2","key":"3794_CR22","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.jsat.2010.08.011","volume":"40","author":"SH Heil","year":"2011","unstructured":"Heil SH, Jones HE, Arria A, Kaltenbach K, Coyle M, Fischer G, et al. Unintended pregnancy in opioid-abusing women. J Subst Abuse Treat. 2011;40(2):199\u2013202.","journal-title":"J Subst Abuse Treat"},{"issue":"9","key":"3794_CR23","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1001\/jamapediatrics.2020.1622","volume":"174","author":"BS Peterson","year":"2020","unstructured":"Peterson BS, Rosen T, Dingman S, Toth ZR, Sawardekar S, Hao X, et al. Associations of maternal prenatal drug abuse with measures of newborn brain structure, tissue organization, and metabolite concentrations. JAMA Pediatr. 2020;174(9):831\u201342.","journal-title":"JAMA Pediatr"},{"issue":"5","key":"3794_CR24","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1017\/neu.2015.12","volume":"27","author":"KA Donald","year":"2015","unstructured":"Donald KA, Eastman E, Howells FM, Adnams C, Riley EP, Woods RP, et al. Neuroimaging effects of prenatal alcohol exposure on the developing human brain: a magnetic resonance imaging review. Acta Neuropsychiatr. 2015;27(5):251\u201369.","journal-title":"Acta Neuropsychiatr"},{"issue":"3","key":"3794_CR25","doi-asserted-by":"publisher","first-page":"e1009","DOI":"10.1542\/peds.2012-3931","volume":"131","author":"M Behnke","year":"2013","unstructured":"Behnke M, Smith VC. Prenatal substance abuse: short- and long-term effects on the exposed fetus. Pediatrics. 2013;131(3):e1009\u201324.","journal-title":"Pediatrics"},{"issue":"7","key":"3794_CR26","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1002\/phar.1954","volume":"37","author":"G Raffaeli","year":"2017","unstructured":"Raffaeli G, Cavallaro G, Allegaert K, Wildschut ED, Fumagalli M, Agosti M, et al. Neonatal Abstinence Syndrome: Update on Diagnostic and Therapeutic Strategies. Pharmacotherapy. 2017;37(7):814\u201323.","journal-title":"Pharmacotherapy"},{"issue":"8","key":"3794_CR27","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1542\/hpeds.2018-0227","volume":"9","author":"LA Sanlorenzo","year":"2019","unstructured":"Sanlorenzo LA, Cooper WO, Dudley JA, Stratton S, Maalouf FI, Patrick SW. Increased severity of neonatal abstinence syndrome associated with concomitant antenatal opioid and benzodiazepine exposure. Hosp Pediatr. 2019;9(8):569\u201375.","journal-title":"Hosp Pediatr"},{"issue":"Suppl 2","key":"3794_CR28","first-page":"S63","volume":"60","author":"RH Stone","year":"2020","unstructured":"Stone RH, Griffin B, Fusco RA, Vest K, Tran T, Gross S. Factors Affecting Contraception Access and Use in Patients With Opioid Use Disorder. J Clin Pharmacol. 2020;60(Suppl 2):S63-s73.","journal-title":"J Clin Pharmacol"},{"key":"3794_CR29","unstructured":"Norwegian Directorate of Health. Guideline on contraceptives for women in opioid substitution therapy Oslo: Norwegian Directorate of Health; 2022 [Available from: https:\/\/www.helsedirektoratet.no\/retningslinjer\/gravide-i-lar\/anbefalinger-om-prevensjon-og-familieplanlegging-legemiddelvalg-og-legemiddeldose-2019."},{"key":"3794_CR30","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.bpobgyn.2019.12.002","volume":"66","author":"L Bahamondes","year":"2020","unstructured":"Bahamondes L, Fernandes A, Monteiro I, Bahamondes MV. Long-acting reversible contraceptive (LARCs) methods. Best Pract Res Clin Obstet Gynaecol. 2020;66:28\u201340.","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"4","key":"3794_CR31","doi-asserted-by":"publisher","first-page":"364.e1","DOI":"10.1016\/j.ajog.2016.12.024","volume":"216","author":"JT Diedrich","year":"2017","unstructured":"Diedrich JT, Klein DA, Peipert JF. Am J Obstet Gynecol. 2017;216(4):364.e1-.e12.","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"3794_CR32","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1097\/AOG.0b013e318273eb56","volume":"120","author":"JF Peipert","year":"2012","unstructured":"Peipert JF, Madden T, Allsworth JE, Secura GM. Preventing unintended pregnancies by providing no-cost contraception. Obstet Gynecol. 2012;120(6):1291\u20137.","journal-title":"Obstet Gynecol"},{"issue":"1","key":"3794_CR33","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.contraception.2018.08.008","volume":"99","author":"A Kotha","year":"2019","unstructured":"Kotha A, Chen BA, Lewis L, Dunn S, Himes KP, Krans EE. Prenatal intent and postpartum receipt of long-acting reversible contraception among women receiving medication-assisted treatment for opioid use disorder. Contraception. 2019;99(1):36\u201341.","journal-title":"Contraception"},{"issue":"2","key":"3794_CR34","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.whi.2018.10.004","volume":"29","author":"M Bornstein","year":"2019","unstructured":"Bornstein M, Gipson JD, Bleck R, Sridhar A, Berger A. Perceptions of Pregnancy and Contraceptive Use: An In-Depth Study of Women in Los Angeles Methadone Clinics. Women\u2019s Health Issues. 2019;29(2):176\u201381.","journal-title":"Women\u2019s Health Issues"},{"issue":"1","key":"3794_CR35","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s12954-021-00532-1","volume":"18","author":"SL Stancil","year":"2021","unstructured":"Stancil SL, Miller MK, Duello A, Finocchario-Kessler S, Goggin K, Winograd RP, et al. Long-acting reversible contraceptives (LARCs) as harm reduction: a qualitative study exploring views of women with histories of opioid misuse. Harm Reduct J. 2021;18(1):83.","journal-title":"Harm Reduct J"},{"issue":"5","key":"3794_CR36","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.contraception.2017.07.167","volume":"96","author":"AK Matusiewicz","year":"2017","unstructured":"Matusiewicz AK, Melbostad HS, Heil SH. Knowledge of and concerns about long-acting reversible contraception among women in medication-assisted treatment for opioid use disorder. Contraception. 2017;96(5):365\u20139.","journal-title":"Contraception"},{"key":"3794_CR37","doi-asserted-by":"publisher","first-page":"108318","DOI":"10.1016\/j.jsat.2021.108318","volume":"126","author":"DJ Rinehart","year":"2021","unstructured":"Rinehart DJ, Stowell M, Collings A, Durfee MJ, Thomas-Gale T, Jones HE, et al. Increasing access to family planning services among women receiving medications for opioid use disorder: A pilot randomized trial examining a peer-led navigation intervention. J Subst Abuse Treat. 2021;126:108318.","journal-title":"J Subst Abuse Treat"},{"issue":"Suppl 1","key":"3794_CR38","first-page":"27","volume":"10","author":"KI Black","year":"2016","unstructured":"Black KI, Day CA. Improving access to long-acting contraceptive methods and reducing unplanned pregnancy among women with substance use disorders. Subs Abuse. 2016;10(Suppl 1):27\u201333.","journal-title":"Subs Abuse"},{"key":"3794_CR39","unstructured":"Cooper DB, McCathran CE. Cervical Dysplasia. StatPearls. Treasure Island (FL): StatPearls Publishing, Copyright \u00a9 2024, StatPearls Publishing LLC.; 2024."},{"key":"3794_CR40","unstructured":"Cancer registry of Norway. Flytskjema Oslo: Kreftregisteret; 2022 [Available from: https:\/\/www.kreftregisteret.no\/globalassets\/livmorhalsprogrammet\/algoritmerflytskjema\/2023\/flytskjema_lp_2023_jan_v3.pdf."},{"key":"3794_CR41","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.chiabu.2017.05.005","volume":"70","author":"M Canfield","year":"2017","unstructured":"Canfield M, Radcliffe P, Marlow S, Boreham M, Gilchrist G. Maternal substance use and child protection: a rapid evidence assessment of factors associated with loss of child care. Child Abuse Negl. 2017;70:11\u201327.","journal-title":"Child Abuse Negl"},{"issue":"10","key":"3794_CR42","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1111\/j.1651-2227.2011.02317.x","volume":"100","author":"T Sarkola","year":"2011","unstructured":"Sarkola T, Gissler M, Kahila H, Autti-R\u00e4m\u00f6 I, Halmesm\u00e4ki E. Early healthcare utilization and welfare interventions among children of mothers with alcohol and substance abuse: a retrospective cohort study. Acta Paediatr. 2011;100(10):1379\u201385.","journal-title":"Acta Paediatr"},{"issue":"11","key":"3794_CR43","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1111\/j.1651-2227.2007.00474.x","volume":"96","author":"T Sarkola","year":"2007","unstructured":"Sarkola T, Kahila H, Gissler M, Halmesm\u00e4ki E. Risk factors for out-of-home custody child care among families with alcohol and substance abuse problems. Acta Paediatr. 2007;96(11):1571\u20136.","journal-title":"Acta Paediatr"},{"issue":"1","key":"3794_CR44","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.drugalcdep.2004.09.005","volume":"78","author":"S Pirard","year":"2005","unstructured":"Pirard S, Sharon E, Kang SK, Angarita GA, Gastfriend DR. Prevalence of physical and sexual abuse among substance abuse patients and impact on treatment outcomes. Drug Alcohol Depend. 2005;78(1):57\u201364.","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"3794_CR45","doi-asserted-by":"publisher","first-page":"1849909","DOI":"10.1080\/22423982.2020.1849909","volume":"80","author":"SV Leth","year":"2021","unstructured":"Leth SV, Bjerrum ML, Niclasen BV. Polysubstance abuse among sexually abused in alcohol, drug, and gambling addiction treatment in Greenland: a cross sectional study. Int J Circumpolar Health. 2021;80(1):1849909.","journal-title":"Int J Circumpolar Health"},{"issue":"8","key":"3794_CR46","doi-asserted-by":"publisher","first-page":"e1115","DOI":"10.1016\/S2214-109X(22)00241-8","volume":"10","author":"L Bruni","year":"2022","unstructured":"Bruni L, Serrano B, Roura E, Alemany L, Cowan M, Herrero R, et al. Cervical cancer screening programmes and age-specific coverage estimates for 202 countries and territories worldwide: a review and synthetic analysis. Lancet Glob Health. 2022;10(8):e1115\u201327.","journal-title":"Lancet Glob Health"},{"issue":"4","key":"3794_CR47","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.ajog.2015.10.147","volume":"214","author":"BF Lees","year":"2016","unstructured":"Lees BF, Erickson BK, Huh WK. Cervical cancer screening: evidence behind the guidelines. Am J Obstet Gynecol. 2016;214(4):438\u201343.","journal-title":"Am J Obstet Gynecol"},{"issue":"7","key":"3794_CR48","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1007\/s10552-013-0224-y","volume":"24","author":"A Kricker","year":"2013","unstructured":"Kricker A, Burns L, Goumas C, Armstrong BK. Cervical screening, high-grade squamous lesions, and cervical cancer in illicit drug users. Cancer Causes Control. 2013;24(7):1449\u201357.","journal-title":"Cancer Causes Control"},{"issue":"5","key":"3794_CR49","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1111\/j.1479-828X.2007.00769.x","volume":"47","author":"A Reece","year":"2007","unstructured":"Reece A. Lifetime prevalence of cervical neoplasia in addicted and medical patients. Aust N Z J Obstet Gynaecol. 2007;47(5):419\u201323.","journal-title":"Aust N Z J Obstet Gynaecol"},{"issue":"3","key":"3794_CR50","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1111\/j.1753-6405.2011.00682.x","volume":"35","author":"D Randall","year":"2011","unstructured":"Randall D, Degenhardt L, Vajdic CM, Burns L, Hall WD, Law M, et al. Increasing cancer mortality among opioid-dependent persons in Australia: a new public health challenge for a disadvantaged population. Aust N Z J Public Health. 2011;35(3):220\u20135.","journal-title":"Aust N Z J Public Health"},{"issue":"1","key":"3794_CR51","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1186\/s12889-023-15236-3","volume":"23","author":"L Garpenhag","year":"2023","unstructured":"Garpenhag L, Dahlman D. Participation in screening for breast and cervical cancer among women with current or previous drug use: a survey study. BMC Public Health. 2023;23(1):352.","journal-title":"BMC Public Health"},{"key":"3794_CR52","unstructured":"Cancer registry of Norway. Yearly report from the cervical screening program Oslo: Cancer registry of Norway; 2022 [cited 2022 29.12.]. Available from: https:\/\/www.kreftregisteret.no\/globalassets\/livmorhalsprogrammet\/rapporter\/arsrapport-lp\/arsrapportlp_2021_final2.pdf."},{"key":"3794_CR53","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.gore.2019.03.016","volume":"28","author":"LA Rubinsak","year":"2019","unstructured":"Rubinsak LA, Terplan M, Martin CE, Fields EC, McGuire WP, Temkin SM. Co-occurring substance use disorder: The impact on treatment adherence in women with locally advanced cervical cancer. Gynecol Oncol Rep. 2019;28:116\u20139.","journal-title":"Gynecol Oncol Rep"},{"key":"3794_CR54","unstructured":"Cambridge University Press. Substance use disorders and sexually transmitted infections: a public health perspective Cambridge: Cambridge University Press,; 2018 [Available from: https:\/\/www.cambridge.org\/core\/journals\/bjpsych-advances\/article\/substance-use-disorders-and-sexually-transmitted-infections-a-public-health-perspective\/65EC0021CB2675831FCB4F73E6B5FDEE."},{"issue":"1","key":"3794_CR55","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1186\/s12889-021-11630-x","volume":"21","author":"A Sent\u00eds","year":"2021","unstructured":"Sent\u00eds A, Prats-Uribe A, L\u00f3pez-Corbeto E, Montoro-Fernandez M, Nomah DK, de Olalla PG, et al. The impact of the COVID-19 pandemic on Sexually Transmitted Infections surveillance data: incidence drop or artefact? BMC Public Health. 2021;21(1):1637.","journal-title":"BMC Public Health"},{"issue":"4","key":"3794_CR56","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1097\/GRF.0000000000000070","volume":"57","author":"C McNicholas","year":"2014","unstructured":"McNicholas C, Madden T, Secura G, Peipert JF. The contraceptive CHOICE project round up: what we did and what we learned. Clin Obstet Gynecol. 2014;57(4):635\u201343.","journal-title":"Clin Obstet Gynecol"},{"issue":"9","key":"3794_CR57","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1111\/add.13840","volume":"112","author":"G Griffith","year":"2017","unstructured":"Griffith G, Kumaraswami T, Chrysanthopoulou SA, Mattocks KM, Clark RE. Prescription contraception use and adherence by women with substance use disorders. Addiction (Abingdon, England). 2017;112(9):1638\u201346.","journal-title":"Addiction (Abingdon, England)"},{"issue":"11","key":"3794_CR58","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1080\/10826084.2016.1188944","volume":"51","author":"N Robinowitz","year":"2016","unstructured":"Robinowitz N, Muqueeth S, Scheibler J, Salisbury-Afshar E, Terplan M. Family planning in substance use disorder treatment centers: opportunities and challenges. Subst Use Misuse. 2016;51(11):1477\u201383.","journal-title":"Subst Use Misuse"}],"container-title":["BMC Women's Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-025-03794-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12905-025-03794-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-025-03794-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,24]],"date-time":"2025-05-24T19:02:34Z","timestamp":1748113354000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcwomenshealth.biomedcentral.com\/articles\/10.1186\/s12905-025-03794-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,24]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3794"],"URL":"https:\/\/doi.org\/10.1186\/s12905-025-03794-0","relation":{},"ISSN":["1472-6874"],"issn-type":[{"value":"1472-6874","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,24]]},"assertion":[{"value":"30 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study received approval from the Regional Committee for Medical and Health Research Ethics in Central Norway (folder No. 29325). Additionally, the protocol was reviewed and approved by the Department of Research and Development of Obstetrics and Gynecology, St. Olavs hospital, Trondheim University Hospital (Elements No. 2019\/6463) prior to the commencement of the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"252"}}